Global Consumer Health Market Overview, Size, Share and Trends 2021-2026

[WISEGUYREPORT]

The outbreak and development of Coronavirus (COVID-19) from early March 2020 halted the economic improvement in the country. Lockdown and other restrictions on business, education and cultural institutions and the population in general fed into rising unemployment, wage cuts and reduced disposable incomes as the government tried to contain the spread of the virus. Economic recession is limiting consumer confidence, leading to a focus on essential products. Thus, the pandemic has generally had a...

Also Read :-http://www.marketwatch.com/story/global-acute-lymphoblastic-leukemi...

Euromonitor International's Consumer Health in Poland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Also Read :-http://www.marketwatch.com/story/global-bluetooth-headsets-market-i...

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Also Read :-http://www.marketwatch.com/story/aerial-imaging-in-insurance-servic...

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Table of Contant

Consumer Health in Poland
Euromonitor International
November 2020

List OF CONTENTS AND TABLES

EXECUTIVE SUMMARY
COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 2 Life Expectancy at Birth 2015-2020
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2015-2020
Table 4 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 5 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 6 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 7 Distribution of Consumer Health by Format: % Value 2015-2020
Table 8 Distribution of Consumer Health by Format and Category: % Value 2020
Table 9 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

Also Read :-http://www.marketwatch.com/story/global-managed-print-services-mark...

APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2019-2020
GLOBAL MACROECONOMIC ENVIRONMENT
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources
KEY DATA FINDINGS
2020 IMPACT
Coronavirus (COVID-19) leads to panic buying as consumers fear running out of analgesics perceived to offer relief from virus symptoms and effects
Ketoprofen sees fast sales growth following switch from RX to OTC as consumers look for strong painkillers over the counter
Advertising remains the key competitive tool as new launches tend to refresh rather than act as game changers
RECOVERY AND OPPORTUNITIES
Long-established preference for self-medication and fast pain relief favours further sales growth in the forecast period
E-commerce set to continue to benefit from convenience and safety perception, although key retail channels remain open and preferred
Manufacturers look to products for specific pain problems under large umbrella brands to stand out from the crowd
CATEGORY DATA
Table 11 Sales of Analgesics by Category: Value 2015-2020
Table 12 Sales of Analgesics by Category: % Value Growth 2015-2020
Table 13 NBO Company Shares of Analgesics: % Value 2016-2020
Table 14 LBN Brand Shares of Analgesics: % Value 2017-2020
Table 15 Forecast Sales of Analgesics by Category: Value 2020-2025
Table 16 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT

Also Read :-http://www.marketwatch.com/story/global-commercial-aircraft-seating...

The early stage of Coronavirus (COVID-19) sees stockpiling as consumers fear product shortages
COVID-19 and a strong self-medication trend offset the adverse sales factors of a mild winter and increase in flu vaccinations
The leading company and channel come under pressure due to fragmentation in the competitive landscape and distribution
RECOVERY AND OPPORTUNITIES
Healthy growth anticipated although category maturity places a premium on marketing and promotional activities to stand out from the crowd
Strong self-medication trend and rising number of allergy sufferers offer growth opportunities
RX to OTC switches predicted to boost sales, although legal restrictions on specific substances may slow development in the category
CATEGORY DATA
Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
Table 19 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
Table 20 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Lockdown creates some opportunities for digestive remedies but travel restrictions hurt motion sickness remedies
Zaklady Farmaceutyczne Polpharma’s new formula response to withdrawal of drugs containing ranitidine is a hit
Leading players leverage strong ranges and marketing to stay ahead of the field
RECOVERY AND OPPORTUNITIES
Consumer lifestyles and preference for self-medication expected to foster sales opportunities for digestive remedies
Healthier and natural lifestyle trends increase the interest in herbal/traditional digestive remedies
Advertising remains a key way to raise awareness, engage with consumers and stand out in a competitive landscape
CATEGORY DATA
Table 23 Sales of Digestive Remedies by Category: Value 2015-2020
Table 24 Sales of Digestive Remedies by Category: % Value Growth 2015-2020
Table 25 NBO Company Shares of Digestive Remedies: % Value 2016-2020
Table 26 LBN Brand Shares of Digestive Remedies: % Value 2017-2020
Table 27 Forecast Sales of Digestive Remedies by Category: Value 2020-2025
Table 28 Forecast Sales of Digestive Remedies by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Coronavirus (COVID-19) checks sales development by limiting exposure to key risk factors
Consumers seeking specialised and effective treatments for skin problems turn to dermatologicals earlier
GSK Consumer Healthcare develops strong niches to retain leadership of a highly fragmented competitive landscape
RECOVERY AND OPPORTUNITIES
Lingering threat and effects of COVID-19 set to hinder sales development in the early forecast period
Low incidence of skin testing presents obstacle to product awareness and sales of dermatologicals
Dermocosmetics set to challenge but not replace dermatologicals as consumers look to treat rather than mask skin problems in the longer term
CATEGORY DATA
Table 29 Sales of Dermatologicals by Category: Value 2015-2020
Table 30 Sales of Dermatologicals by Category: % Value Growth 2015-2020
Table 31 NBO Company Shares of Dermatologicals: % Value 2016-2020
Table 32 LBN Brand Shares of Dermatologicals: % Value 2017-2020
Table 33 LBN Brand Shares of Hair Loss Treatments: % Value 2017-2020
Table 34 Forecast Sales of Dermatologicals by Category: Value 2020-2025
Table 35 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Coronavirus (COVID-19) boosts sales by adding a new dimension to awareness of smoking’s potential harmful effects on health
Receding acceptance and prevalence of smoking offer growth opportunities for NRT smoking cessation aids
Johnson & Johnson dominates with a wide portfolio and a strong marketing presence
RECOVERY AND OPPORTUNITIES
Positive outlook as COVID-19 increases number of smokers looking to quit the habit among a still large smoking population
Young consumers’ acceptance of e-vapour products as simple-to-use, smokeless and flavoursome alternatives threaten NRT smoking cessation aids
Heated tobacco emerges as a potential substitute for NRT smoking cessation aids as it is perceived to be “safer” and retains opportunities to taste menthol
CATEGORY INDICATORS
Table 36 Number of Smokers by Gender 2015-2020
CATEGORY DATA
Table 37 Sales of NRT Smoking Cessation Aids by Category: Value 2015-2020
Table 38 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2015-2020
Table 39 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2016-2020
Table 40 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2017-2020
Table 41 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2020-2025
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Fast sales growth for sleep aids as Coronavirus (COVID-19) aggravates conditions that contribute to sleep disorders
Modern lifestyles increase incidence of sleeping problems and hasten recourse to sleep aids for fast relief
Level of consolidation as the top three brands see significant retail value share growth at the end of the review period
RECOVERY AND OPPORTUNITIES
Modern living, residual COVID-19 effects and ageing population trend offer positive outlook for sleep aids
Consumers prefer milder herbal to stronger standard products, although similarly-positioned food supplements offer enticing alternatives
Sleep aids set to remain first port of call as consumers lack of awareness of sleep health and institutional framework remains weak
CATEGORY DATA
Table 43 Sales of Sleep Aids: Value 2015-2020
Table 44 Sales of Sleep Aids: % Value Growth 2015-2020
Table 45 NBO Company Shares of Sleep Aids: % Value 2016-2020
Table 46 LBN Brand Shares of Sleep Aids: % Value 2017-2020
Table 47 Forecast Sales of Sleep Aids: Value 2020-2025
Table 48 Forecast Sales of Sleep Aids: % Value Growth 2020-2025

…. Continued

CONTACT DETAILS :

[e-mail]

[phone]

[phone]

971 0503084105